I-South African Health Products Regulatory Authority ikhiphe isexwayiso ngemithi yokuvimbela inzalo nemithi yomdlavuza equkethe ikhemikhali ebizwa nge-medroxyprogesterone acetate(MPA) ukuthi ingeminye edala ezimila ebuchosheni.
Kodwa-ke, ubungozi besephansi, ngamacala angama-32 kuphela emhlabeni eminyakeni engama-20.
UMadimetja Mashishi we-SAHPRA uthi ochwepheshe bezempilo kufanele baqaphe izimpawu, kuyilapho iziguli zinxuswa ukuthi zixoxe ngezingozi futhi zilandele izeluleko zezokwelapha.
“I-meningioma isimila esivame ukungabi nawo umdlavuza esikhula olwelwesini oluzungeze ubuchopho nomgogodla,” kusho uMashishi.
“Isinqumo se-SAHPRA silandela ubufakazi bophenyo elwenzile oluveza ukwanda kwengozi ye-meningioma kubantu abasebenzisa imikhiqizo ene-MPA.”